HomeTagsVantAI

Tag: VantAI

Healthcare

VantAI & Blueprint Expand Tie-Up on Proximity Drug Discovery

Collaboration will extend work to prioritize valuable novel target-effector pairs, ideal for subsequent molecular glue development, including aiming at targets previously considered undruggable through...

Healthcare

VantAI Launches Neo-1, the First AI Model to Rewire Molecular Interactions by Unifying Structure Prediction and Generation for Therapeutic Design

VantAI unveiled Neo-1, the world’s most advanced atomistic foundation model and the first to unify de novo molecular generation with multimodal structure prediction, at...

Healthcare

VantAI Appoints John Cuozzo as Senior Vice President, Head of Drug Discovery

VantAI, a leader in generative AI and drug discovery, announced the appointment of John Cuozzo, PhD as SVP, Head of Drug Discovery. Cuozzo is...

Healthcare

VantAI Collaborates With Google Cloud to Harness NVIDIA GPUs for Building Protein Interaction Foundation Models

VantAI will leverage its proprietary large scale structural data and NVIDIA H100 GPUs on Google Cloud to enable a step-change in accuracy for all-atom...

Healthcare

VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence

Collaboration to leverage VantAI's expertise in generative AI and geometric deep learning to identify molecular glues against targets of interest with an option to...

Healthcare

VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer

VantAI, a leader in generative AI and drug discovery, announced the appointment of Jae Won Kim as Chief Operating Officer (COO) and Chief Financial...